SaaS-Based Expense Management
SaaS-Based Expense Management market is segmented by players, region (country), by Type and by Ap ... Read More
Global Radiopharmaceutical Market Insights and Forecast to 2028
1 Study Coverage
1.1 Radiopharmaceutical Product Introduction
1.2 Market by Type
1.2.1 Global Radiopharmaceutical Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Actinium-225
1.2.3 Lutetium-177
1.2.4 Radium-223
1.2.5 Holmium-166
1.2.6 Other
1.3 Market by Application
1.3.1 Global Radiopharmaceutical Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Radiopharmaceutical Sales Estimates and Forecasts 2017-2028
2.2 Global Radiopharmaceutical Revenue Estimates and Forecasts 2017-2028
2.3 Global Radiopharmaceutical Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Radiopharmaceutical Sales by Region
2.4.1 Global Radiopharmaceutical Sales by Region (2017-2022)
2.4.2 Global Sales Radiopharmaceutical by Region (2023-2028)
2.5 Global Radiopharmaceutical Revenue by Region
2.5.1 Global Radiopharmaceutical Revenue by Region (2017-2022)
2.5.2 Global Radiopharmaceutical Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Radiopharmaceutical Sales by Manufacturers
3.1.1 Global Top Radiopharmaceutical Manufacturers by Sales (2017-2022)
3.1.2 Global Radiopharmaceutical Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Radiopharmaceutical in 2021
3.2 Global Radiopharmaceutical Revenue by Manufacturers
3.2.1 Global Radiopharmaceutical Revenue by Manufacturers (2017-2022)
3.2.2 Global Radiopharmaceutical Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Radiopharmaceutical Revenue in 2021
3.3 Global Radiopharmaceutical Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Radiopharmaceutical Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Radiopharmaceutical Sales by Type
4.1.1 Global Radiopharmaceutical Historical Sales by Type (2017-2022)
4.1.2 Global Radiopharmaceutical Forecasted Sales by Type (2023-2028)
4.1.3 Global Radiopharmaceutical Sales Market Share by Type (2017-2028)
4.2 Global Radiopharmaceutical Revenue by Type
4.2.1 Global Radiopharmaceutical Historical Revenue by Type (2017-2022)
4.2.2 Global Radiopharmaceutical Forecasted Revenue by Type (2023-2028)
4.2.3 Global Radiopharmaceutical Revenue Market Share by Type (2017-2028)
4.3 Global Radiopharmaceutical Price by Type
4.3.1 Global Radiopharmaceutical Price by Type (2017-2022)
4.3.2 Global Radiopharmaceutical Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Radiopharmaceutical Sales by Application
5.1.1 Global Radiopharmaceutical Historical Sales by Application (2017-2022)
5.1.2 Global Radiopharmaceutical Forecasted Sales by Application (2023-2028)
5.1.3 Global Radiopharmaceutical Sales Market Share by Application (2017-2028)
5.2 Global Radiopharmaceutical Revenue by Application
5.2.1 Global Radiopharmaceutical Historical Revenue by Application (2017-2022)
5.2.2 Global Radiopharmaceutical Forecasted Revenue by Application (2023-2028)
5.2.3 Global Radiopharmaceutical Revenue Market Share by Application (2017-2028)
5.3 Global Radiopharmaceutical Price by Application
5.3.1 Global Radiopharmaceutical Price by Application (2017-2022)
5.3.2 Global Radiopharmaceutical Price Forecast by Application (2023-2028)
6 North America
6.1 North America Radiopharmaceutical Market Size by Type
6.1.1 North America Radiopharmaceutical Sales by Type (2017-2028)
6.1.2 North America Radiopharmaceutical Revenue by Type (2017-2028)
6.2 North America Radiopharmaceutical Market Size by Application
6.2.1 North America Radiopharmaceutical Sales by Application (2017-2028)
6.2.2 North America Radiopharmaceutical Revenue by Application (2017-2028)
6.3 North America Radiopharmaceutical Market Size by Country
6.3.1 North America Radiopharmaceutical Sales by Country (2017-2028)
6.3.2 North America Radiopharmaceutical Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Radiopharmaceutical Market Size by Type
7.1.1 Europe Radiopharmaceutical Sales by Type (2017-2028)
7.1.2 Europe Radiopharmaceutical Revenue by Type (2017-2028)
7.2 Europe Radiopharmaceutical Market Size by Application
7.2.1 Europe Radiopharmaceutical Sales by Application (2017-2028)
7.2.2 Europe Radiopharmaceutical Revenue by Application (2017-2028)
7.3 Europe Radiopharmaceutical Market Size by Country
7.3.1 Europe Radiopharmaceutical Sales by Country (2017-2028)
7.3.2 Europe Radiopharmaceutical Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Radiopharmaceutical Market Size by Type
8.1.1 Asia Pacific Radiopharmaceutical Sales by Type (2017-2028)
8.1.2 Asia Pacific Radiopharmaceutical Revenue by Type (2017-2028)
8.2 Asia Pacific Radiopharmaceutical Market Size by Application
8.2.1 Asia Pacific Radiopharmaceutical Sales by Application (2017-2028)
8.2.2 Asia Pacific Radiopharmaceutical Revenue by Application (2017-2028)
8.3 Asia Pacific Radiopharmaceutical Market Size by Region
8.3.1 Asia Pacific Radiopharmaceutical Sales by Region (2017-2028)
8.3.2 Asia Pacific Radiopharmaceutical Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Radiopharmaceutical Market Size by Type
9.1.1 Latin America Radiopharmaceutical Sales by Type (2017-2028)
9.1.2 Latin America Radiopharmaceutical Revenue by Type (2017-2028)
9.2 Latin America Radiopharmaceutical Market Size by Application
9.2.1 Latin America Radiopharmaceutical Sales by Application (2017-2028)
9.2.2 Latin America Radiopharmaceutical Revenue by Application (2017-2028)
9.3 Latin America Radiopharmaceutical Market Size by Country
9.3.1 Latin America Radiopharmaceutical Sales by Country (2017-2028)
9.3.2 Latin America Radiopharmaceutical Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Radiopharmaceutical Market Size by Type
10.1.1 Middle East and Africa Radiopharmaceutical Sales by Type (2017-2028)
10.1.2 Middle East and Africa Radiopharmaceutical Revenue by Type (2017-2028)
10.2 Middle East and Africa Radiopharmaceutical Market Size by Application
10.2.1 Middle East and Africa Radiopharmaceutical Sales by Application (2017-2028)
10.2.2 Middle East and Africa Radiopharmaceutical Revenue by Application (2017-2028)
10.3 Middle East and Africa Radiopharmaceutical Market Size by Country
10.3.1 Middle East and Africa Radiopharmaceutical Sales by Country (2017-2028)
10.3.2 Middle East and Africa Radiopharmaceutical Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Bracco Imaging
11.1.1 Bracco Imaging Corporation Information
11.1.2 Bracco Imaging Overview
11.1.3 Bracco Imaging Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Bracco Imaging Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Bracco Imaging Recent Developments
11.2 Bayer
11.2.1 Bayer Corporation Information
11.2.2 Bayer Overview
11.2.3 Bayer Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Bayer Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Bayer Recent Developments
11.3 Mallinckrodt
11.3.1 Mallinckrodt Corporation Information
11.3.2 Mallinckrodt Overview
11.3.3 Mallinckrodt Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Mallinckrodt Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Mallinckrodt Recent Developments
11.4 Nordion
11.4.1 Nordion Corporation Information
11.4.2 Nordion Overview
11.4.3 Nordion Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Nordion Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Nordion Recent Developments
11.5 Triad Isotopes
11.5.1 Triad Isotopes Corporation Information
11.5.2 Triad Isotopes Overview
11.5.3 Triad Isotopes Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Triad Isotopes Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Triad Isotopes Recent Developments
11.6 Lantheus
11.6.1 Lantheus Corporation Information
11.6.2 Lantheus Overview
11.6.3 Lantheus Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 Lantheus Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Lantheus Recent Developments
11.7 IBA Group
11.7.1 IBA Group Corporation Information
11.7.2 IBA Group Overview
11.7.3 IBA Group Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 IBA Group Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 IBA Group Recent Developments
11.8 GE Healthcare
11.8.1 GE Healthcare Corporation Information
11.8.2 GE Healthcare Overview
11.8.3 GE Healthcare Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 GE Healthcare Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 GE Healthcare Recent Developments
11.9 China Isotope & Radiation
11.9.1 China Isotope & Radiation Corporation Information
11.9.2 China Isotope & Radiation Overview
11.9.3 China Isotope & Radiation Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 China Isotope & Radiation Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 China Isotope & Radiation Recent Developments
11.10 Jubilant Pharma
11.10.1 Jubilant Pharma Corporation Information
11.10.2 Jubilant Pharma Overview
11.10.3 Jubilant Pharma Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Jubilant Pharma Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Jubilant Pharma Recent Developments
11.11 Eli Lilly
11.11.1 Eli Lilly Corporation Information
11.11.2 Eli Lilly Overview
11.11.3 Eli Lilly Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Eli Lilly Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Eli Lilly Recent Developments
11.12 Advanced Accelerator Applications
11.12.1 Advanced Accelerator Applications Corporation Information
11.12.2 Advanced Accelerator Applications Overview
11.12.3 Advanced Accelerator Applications Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Advanced Accelerator Applications Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Advanced Accelerator Applications Recent Developments
11.13 SIEMENS
11.13.1 SIEMENS Corporation Information
11.13.2 SIEMENS Overview
11.13.3 SIEMENS Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 SIEMENS Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 SIEMENS Recent Developments
11.14 Dongcheng
11.14.1 Dongcheng Corporation Information
11.14.2 Dongcheng Overview
11.14.3 Dongcheng Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 Dongcheng Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Dongcheng Recent Developments
11.15 Navidea
11.15.1 Navidea Corporation Information
11.15.2 Navidea Overview
11.15.3 Navidea Radiopharmaceutical Sales, Price, Revenue and Gross Margin (2017-2022)
11.15.4 Navidea Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Navidea Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Radiopharmaceutical Industry Chain Analysis
12.2 Radiopharmaceutical Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Radiopharmaceutical Production Mode & Process
12.4 Radiopharmaceutical Sales and Marketing
12.4.1 Radiopharmaceutical Sales Channels
12.4.2 Radiopharmaceutical Distributors
12.5 Radiopharmaceutical Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Radiopharmaceutical Industry Trends
13.2 Radiopharmaceutical Market Drivers
13.3 Radiopharmaceutical Market Challenges
13.4 Radiopharmaceutical Market Restraints
14 Key Findings in The Global Radiopharmaceutical Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Radiopharmaceutical Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Actinium-225
Table 3. Major Manufacturers of Lutetium-177
Table 4. Major Manufacturers of Radium-223
Table 5. Major Manufacturers of Holmium-166
Table 6. Major Manufacturers of Other
Table 7. Global Radiopharmaceutical Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 8. Global Radiopharmaceutical Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 9. Global Radiopharmaceutical Sales by Region (2017-2022) & (M Doses)
Table 10. Global Radiopharmaceutical Sales Market Share by Region (2017-2022)
Table 11. Global Radiopharmaceutical Sales by Region (2023-2028) & (M Doses)
Table 12. Global Radiopharmaceutical Sales Market Share by Region (2023-2028)
Table 13. Global Radiopharmaceutical Revenue by Region (2017-2022) & (US$ Million)
Table 14. Global Radiopharmaceutical Revenue Market Share by Region (2017-2022)
Table 15. Global Radiopharmaceutical Revenue by Region (2023-2028) & (US$ Million)
Table 16. Global Radiopharmaceutical Revenue Market Share by Region (2023-2028)
Table 17. Global Radiopharmaceutical Sales by Manufacturers (2017-2022) & (M Doses)
Table 18. Global Radiopharmaceutical Sales Share by Manufacturers (2017-2022)
Table 19. Global Radiopharmaceutical Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 20. Global Radiopharmaceutical Revenue Share by Manufacturers (2017-2022)
Table 21. Radiopharmaceutical Price by Manufacturers (2017-2022) &(USD/Dose)
Table 22. Global Radiopharmaceutical Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Radiopharmaceutical by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Radiopharmaceutical as of 2021)
Table 24. Radiopharmaceutical Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Radiopharmaceutical Product Offered
Table 26. Date of Manufacturers Enter into Radiopharmaceutical Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Radiopharmaceutical Sales by Type (2017-2022) & (M Doses)
Table 29. Global Radiopharmaceutical Sales by Type (2023-2028) & (M Doses)
Table 30. Global Radiopharmaceutical Sales Share by Type (2017-2022)
Table 31. Global Radiopharmaceutical Sales Share by Type (2023-2028)
Table 32. Global Radiopharmaceutical Revenue by Type (2017-2022) & (US$ Million)
Table 33. Global Radiopharmaceutical Revenue by Type (2023-2028) & (US$ Million)
Table 34. Global Radiopharmaceutical Revenue Share by Type (2017-2022)
Table 35. Global Radiopharmaceutical Revenue Share by Type (2023-2028)
Table 36. Radiopharmaceutical Price by Type (2017-2022) & (USD/Dose)
Table 37. Global Radiopharmaceutical Price Forecast by Type (2023-2028) & (USD/Dose)
Table 38. Global Radiopharmaceutical Sales by Application (2017-2022) & (M Doses)
Table 39. Global Radiopharmaceutical Sales by Application (2023-2028) & (M Doses)
Table 40. Global Radiopharmaceutical Sales Share by Application (2017-2022)
Table 41. Global Radiopharmaceutical Sales Share by Application (2023-2028)
Table 42. Global Radiopharmaceutical Revenue by Application (2017-2022) & (US$ Million)
Table 43. Global Radiopharmaceutical Revenue by Application (2023-2028) & (US$ Million)
Table 44. Global Radiopharmaceutical Revenue Share by Application (2017-2022)
Table 45. Global Radiopharmaceutical Revenue Share by Application (2023-2028)
Table 46. Radiopharmaceutical Price by Application (2017-2022) & (USD/Dose)
Table 47. Global Radiopharmaceutical Price Forecast by Application (2023-2028) & (USD/Dose)
Table 48. North America Radiopharmaceutical Sales by Type (2017-2022) & (M Doses)
Table 49. North America Radiopharmaceutical Sales by Type (2023-2028) & (M Doses)
Table 50. North America Radiopharmaceutical Revenue by Type (2017-2022) & (US$ Million)
Table 51. North America Radiopharmaceutical Revenue by Type (2023-2028) & (US$ Million)
Table 52. North America Radiopharmaceutical Sales by Application (2017-2022) & (M Doses)
Table 53. North America Radiopharmaceutical Sales by Application (2023-2028) & (M Doses)
Table 54. North America Radiopharmaceutical Revenue by Application (2017-2022) & (US$ Million)
Table 55. North America Radiopharmaceutical Revenue by Application (2023-2028) & (US$ Million)
Table 56. North America Radiopharmaceutical Sales by Country (2017-2022) & (M Doses)
Table 57. North America Radiopharmaceutical Sales by Country (2023-2028) & (M Doses)
Table 58. North America Radiopharmaceutical Revenue by Country (2017-2022) & (US$ Million)
Table 59. North America Radiopharmaceutical Revenue by Country (2023-2028) & (US$ Million)
Table 60. Europe Radiopharmaceutical Sales by Type (2017-2022) & (M Doses)
Table 61. Europe Radiopharmaceutical Sales by Type (2023-2028) & (M Doses)
Table 62. Europe Radiopharmaceutical Revenue by Type (2017-2022) & (US$ Million)
Table 63. Europe Radiopharmaceutical Revenue by Type (2023-2028) & (US$ Million)
Table 64. Europe Radiopharmaceutical Sales by Application (2017-2022) & (M Doses)
Table 65. Europe Radiopharmaceutical Sales by Application (2023-2028) & (M Doses)
Table 66. Europe Radiopharmaceutical Revenue by Application (2017-2022) & (US$ Million)
Table 67. Europe Radiopharmaceutical Revenue by Application (2023-2028) & (US$ Million)
Table 68. Europe Radiopharmaceutical Sales by Country (2017-2022) & (M Doses)
Table 69. Europe Radiopharmaceutical Sales by Country (2023-2028) & (M Doses)
Table 70. Europe Radiopharmaceutical Revenue by Country (2017-2022) & (US$ Million)
Table 71. Europe Radiopharmaceutical Revenue by Country (2023-2028) & (US$ Million)
Table 72. Asia Pacific Radiopharmaceutical Sales by Type (2017-2022) & (M Doses)
Table 73. Asia Pacific Radiopharmaceutical Sales by Type (2023-2028) & (M Doses)
Table 74. Asia Pacific Radiopharmaceutical Revenue by Type (2017-2022) & (US$ Million)
Table 75. Asia Pacific Radiopharmaceutical Revenue by Type (2023-2028) & (US$ Million)
Table 76. Asia Pacific Radiopharmaceutical Sales by Application (2017-2022) & (M Doses)
Table 77. Asia Pacific Radiopharmaceutical Sales by Application (2023-2028) & (M Doses)
Table 78. Asia Pacific Radiopharmaceutical Revenue by Application (2017-2022) & (US$ Million)
Table 79. Asia Pacific Radiopharmaceutical Revenue by Application (2023-2028) & (US$ Million)
Table 80. Asia Pacific Radiopharmaceutical Sales by Region (2017-2022) & (M Doses)
Table 81. Asia Pacific Radiopharmaceutical Sales by Region (2023-2028) & (M Doses)
Table 82. Asia Pacific Radiopharmaceutical Revenue by Region (2017-2022) & (US$ Million)
Table 83. Asia Pacific Radiopharmaceutical Revenue by Region (2023-2028) & (US$ Million)
Table 84. Latin America Radiopharmaceutical Sales by Type (2017-2022) & (M Doses)
Table 85. Latin America Radiopharmaceutical Sales by Type (2023-2028) & (M Doses)
Table 86. Latin America Radiopharmaceutical Revenue by Type (2017-2022) & (US$ Million)
Table 87. Latin America Radiopharmaceutical Revenue by Type (2023-2028) & (US$ Million)
Table 88. Latin America Radiopharmaceutical Sales by Application (2017-2022) & (M Doses)
Table 89. Latin America Radiopharmaceutical Sales by Application (2023-2028) & (M Doses)
Table 90. Latin America Radiopharmaceutical Revenue by Application (2017-2022) & (US$ Million)
Table 91. Latin America Radiopharmaceutical Revenue by Application (2023-2028) & (US$ Million)
Table 92. Latin America Radiopharmaceutical Sales by Country (2017-2022) & (M Doses)
Table 93. Latin America Radiopharmaceutical Sales by Country (2023-2028) & (M Doses)
Table 94. Latin America Radiopharmaceutical Revenue by Country (2017-2022) & (US$ Million)
Table 95. Latin America Radiopharmaceutical Revenue by Country (2023-2028) & (US$ Million)
Table 96. Middle East and Africa Radiopharmaceutical Sales by Type (2017-2022) & (M Doses)
Table 97. Middle East and Africa Radiopharmaceutical Sales by Type (2023-2028) & (M Doses)
Table 98. Middle East and Africa Radiopharmaceutical Revenue by Type (2017-2022) & (US$ Million)
Table 99. Middle East and Africa Radiopharmaceutical Revenue by Type (2023-2028) & (US$ Million)
Table 100. Middle East and Africa Radiopharmaceutical Sales by Application (2017-2022) & (M Doses)
Table 101. Middle East and Africa Radiopharmaceutical Sales by Application (2023-2028) & (M Doses)
Table 102. Middle East and Africa Radiopharmaceutical Revenue by Application (2017-2022) & (US$ Million)
Table 103. Middle East and Africa Radiopharmaceutical Revenue by Application (2023-2028) & (US$ Million)
Table 104. Middle East and Africa Radiopharmaceutical Sales by Country (2017-2022) & (M Doses)
Table 105. Middle East and Africa Radiopharmaceutical Sales by Country (2023-2028) & (M Doses)
Table 106. Middle East and Africa Radiopharmaceutical Revenue by Country (2017-2022) & (US$ Million)
Table 107. Middle East and Africa Radiopharmaceutical Revenue by Country (2023-2028) & (US$ Million)
Table 108. Bracco Imaging Corporation Information
Table 109. Bracco Imaging Description and Major Businesses
Table 110. Bracco Imaging Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 111. Bracco Imaging Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 112. Bracco Imaging Recent Developments
Table 113. Bayer Corporation Information
Table 114. Bayer Description and Major Businesses
Table 115. Bayer Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 116. Bayer Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 117. Bayer Recent Developments
Table 118. Mallinckrodt Corporation Information
Table 119. Mallinckrodt Description and Major Businesses
Table 120. Mallinckrodt Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 121. Mallinckrodt Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 122. Mallinckrodt Recent Developments
Table 123. Nordion Corporation Information
Table 124. Nordion Description and Major Businesses
Table 125. Nordion Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 126. Nordion Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 127. Nordion Recent Developments
Table 128. Triad Isotopes Corporation Information
Table 129. Triad Isotopes Description and Major Businesses
Table 130. Triad Isotopes Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 131. Triad Isotopes Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 132. Triad Isotopes Recent Developments
Table 133. Lantheus Corporation Information
Table 134. Lantheus Description and Major Businesses
Table 135. Lantheus Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 136. Lantheus Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 137. Lantheus Recent Developments
Table 138. IBA Group Corporation Information
Table 139. IBA Group Description and Major Businesses
Table 140. IBA Group Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 141. IBA Group Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 142. IBA Group Recent Developments
Table 143. GE Healthcare Corporation Information
Table 144. GE Healthcare Description and Major Businesses
Table 145. GE Healthcare Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 146. GE Healthcare Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 147. GE Healthcare Recent Developments
Table 148. China Isotope & Radiation Corporation Information
Table 149. China Isotope & Radiation Description and Major Businesses
Table 150. China Isotope & Radiation Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 151. China Isotope & Radiation Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 152. China Isotope & Radiation Recent Developments
Table 153. Jubilant Pharma Corporation Information
Table 154. Jubilant Pharma Description and Major Businesses
Table 155. Jubilant Pharma Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 156. Jubilant Pharma Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 157. Jubilant Pharma Recent Developments
Table 158. Eli Lilly Corporation Information
Table 159. Eli Lilly Description and Major Businesses
Table 160. Eli Lilly Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 161. Eli Lilly Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 162. Eli Lilly Recent Developments
Table 163. Advanced Accelerator Applications Corporation Information
Table 164. Advanced Accelerator Applications Description and Major Businesses
Table 165. Advanced Accelerator Applications Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 166. Advanced Accelerator Applications Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 167. Advanced Accelerator Applications Recent Developments
Table 168. SIEMENS Corporation Information
Table 169. SIEMENS Description and Major Businesses
Table 170. SIEMENS Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 171. SIEMENS Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 172. SIEMENS Recent Developments
Table 173. Dongcheng Corporation Information
Table 174. Dongcheng Description and Major Businesses
Table 175. Dongcheng Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 176. Dongcheng Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 177. Dongcheng Recent Developments
Table 178. Navidea Corporation Information
Table 179. Navidea Description and Major Businesses
Table 180. Navidea Radiopharmaceutical Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2017-2022)
Table 181. Navidea Radiopharmaceutical Product Model Numbers, Pictures, Descriptions and Specifications
Table 182. Navidea Recent Developments
Table 183. Key Raw Materials Lists
Table 184. Raw Materials Key Suppliers Lists
Table 185. Radiopharmaceutical Distributors List
Table 186. Radiopharmaceutical Customers List
Table 187. Radiopharmaceutical Market Trends
Table 188. Radiopharmaceutical Market Drivers
Table 189. Radiopharmaceutical Market Challenges
Table 190. Radiopharmaceutical Market Restraints
Table 191. Research Programs/Design for This Report
Table 192. Key Data Information from Secondary Sources
Table 193. Key Data Information from Primary Sources
List of Figures
Figure 1. Radiopharmaceutical Product Picture
Figure 3. Global Radiopharmaceutical Market Share by Type in 2021 & 2028
Figure 3. Actinium-225 Product Picture
Figure 4. Lutetium-177 Product Picture
Figure 5. Radium-223 Product Picture
Figure 6. Holmium-166 Product Picture
Figure 7. Other Product Picture
Figure 8. Global Radiopharmaceutical Market Share by Application in 2021 & 2028
Figure 9. Oncology
Figure 10. Cardiology
Figure 11. Other
Figure 12. Radiopharmaceutical Report Years Considered
Figure 13. Global Radiopharmaceutical Sales 2017-2028 (M Doses)
Figure 14. Global Radiopharmaceutical Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 15. Global Radiopharmaceutical Revenue 2017-2028 (US$ Million)
Figure 16. Global Radiopharmaceutical Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 17. Global Radiopharmaceutical Sales Market Share by Region (2017-2022)
Figure 18. Global Radiopharmaceutical Sales Market Share by Region (2023-2028)
Figure 19. North America Radiopharmaceutical Sales YoY (2017-2028) & (M Doses)
Figure 20. North America Radiopharmaceutical Revenue YoY (2017-2028) & (US$ Million)
Figure 21. Europe Radiopharmaceutical Sales YoY (2017-2028) & (M Doses)
Figure 22. Europe Radiopharmaceutical Revenue YoY (2017-2028) & (US$ Million)
Figure 23. Asia-Pacific Radiopharmaceutical Sales YoY (2017-2028) & (M Doses)
Figure 24. Asia-Pacific Radiopharmaceutical Revenue YoY (2017-2028) & (US$ Million)
Figure 25. Latin America Radiopharmaceutical Sales YoY (2017-2028) & (M Doses)
Figure 26. Latin America Radiopharmaceutical Revenue YoY (2017-2028) & (US$ Million)
Figure 27. Middle East & Africa Radiopharmaceutical Sales YoY (2017-2028) & (M Doses)
Figure 28. Middle East & Africa Radiopharmaceutical Revenue YoY (2017-2028) & (US$ Million)
Figure 29. The Radiopharmaceutical Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 30. The Top 5 and 10 Largest Manufacturers of Radiopharmaceutical in the World: Market Share by Radiopharmaceutical Revenue in 2021
Figure 31. Global Radiopharmaceutical Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 32. Global Radiopharmaceutical Sales Market Share by Type (2017-2028)
Figure 33. Global Radiopharmaceutical Revenue Market Share by Type (2017-2028)
Figure 34. Global Radiopharmaceutical Sales Market Share by Application (2017-2028)
Figure 35. Global Radiopharmaceutical Revenue Market Share by Application (2017-2028)
Figure 36. North America Radiopharmaceutical Sales Market Share by Type (2017-2028)
Figure 37. North America Radiopharmaceutical Revenue Market Share by Type (2017-2028)
Figure 38. North America Radiopharmaceutical Sales Market Share by Application (2017-2028)
Figure 39. North America Radiopharmaceutical Revenue Market Share by Application (2017-2028)
Figure 40. North America Radiopharmaceutical Sales Share by Country (2017-2028)
Figure 41. North America Radiopharmaceutical Revenue Share by Country (2017-2028)
Figure 42. U.S. Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 43. Canada Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 44. Europe Radiopharmaceutical Sales Market Share by Type (2017-2028)
Figure 45. Europe Radiopharmaceutical Revenue Market Share by Type (2017-2028)
Figure 46. Europe Radiopharmaceutical Sales Market Share by Application (2017-2028)
Figure 47. Europe Radiopharmaceutical Revenue Market Share by Application (2017-2028)
Figure 48. Europe Radiopharmaceutical Sales Share by Country (2017-2028)
Figure 49. Europe Radiopharmaceutical Revenue Share by Country (2017-2028)
Figure 50. Germany Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 51. France Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 52. U.K. Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 53. Italy Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 54. Russia Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 55. Asia Pacific Radiopharmaceutical Sales Market Share by Type (2017-2028)
Figure 56. Asia Pacific Radiopharmaceutical Revenue Market Share by Type (2017-2028)
Figure 57. Asia Pacific Radiopharmaceutical Sales Market Share by Application (2017-2028)
Figure 58. Asia Pacific Radiopharmaceutical Revenue Market Share by Application (2017-2028)
Figure 59. Asia Pacific Radiopharmaceutical Sales Share by Region (2017-2028)
Figure 60. Asia Pacific Radiopharmaceutical Revenue Share by Region (2017-2028)
Figure 61. China Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 62. Japan Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 63. South Korea Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 64. India Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 65. Australia Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 66. Taiwan Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 67. Indonesia Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 68. Thailand Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 69. Malaysia Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 70. Philippines Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 71. Latin America Radiopharmaceutical Sales Market Share by Type (2017-2028)
Figure 72. Latin America Radiopharmaceutical Revenue Market Share by Type (2017-2028)
Figure 73. Latin America Radiopharmaceutical Sales Market Share by Application (2017-2028)
Figure 74. Latin America Radiopharmaceutical Revenue Market Share by Application (2017-2028)
Figure 75. Latin America Radiopharmaceutical Sales Share by Country (2017-2028)
Figure 76. Latin America Radiopharmaceutical Revenue Share by Country (2017-2028)
Figure 77. Mexico Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 78. Brazil Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 79. Argentina Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 80. Middle East and Africa Radiopharmaceutical Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Radiopharmaceutical Revenue Market Share by Type (2017-2028)
Figure 82. Middle East and Africa Radiopharmaceutical Sales Market Share by Application (2017-2028)
Figure 83. Middle East and Africa Radiopharmaceutical Revenue Market Share by Application (2017-2028)
Figure 84. Middle East and Africa Radiopharmaceutical Sales Share by Country (2017-2028)
Figure 85. Middle East and Africa Radiopharmaceutical Revenue Share by Country (2017-2028)
Figure 86. Turkey Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 87. Saudi Arabia Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 88. U.A.E Radiopharmaceutical Revenue (2017-2028) & (US$ Million)
Figure 89. Radiopharmaceutical Value Chain
Figure 90. Radiopharmaceutical Production Process
Figure 91. Channels of Distribution
Figure 92. Distributors Profiles
Figure 93. Bottom-up and Top-down Approaches for This Report
Figure 94. Data Triangulation
Figure 95. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Bracco Imaging Bayer Mallinckrodt Nordion Triad Isotopes Lantheus IBA Group GE Healthcare China Isotope & Radiation Jubilant Pharma Eli Lilly Advanced Accelerator Applications SIEMENS Dongcheng Navidea